Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LHD-PH Fasudil Hemodynamic Study
jRCTs041180123Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fasudil in pulmonary hypertension due to left heart disease (PH-LHD) and heart failure (HF) (2 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Change in pulmonary vascular resistance in reactive pulmonary hypertension. Started Jul 2016; status: completed.
02
Drugs
fasudil
03
Conditions
pulmonary hypertension due to left heart disease (PH-LHD)heart failure (HF)
Beyond the preview
Go deeper on jRCTs041180123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180123.